Oxaliplatin resistance - Open Access .click

Results 291 to 300 of about 47,533 (300)

Some of the next articles are maybe not open access.

Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma

FEBS Letters, 2002
Laure Crabbe, Pierre Martineau, Nadir Mechti +2 more
exaly

Inhibition of B7-H3 reverses oxaliplatin resistance in human colorectal cancer cells

Biochemical and Biophysical Research Communications, 2017
Pengfei Zhang, Kuan Ning, Jian Jin
exaly

Oxaliplatin for the treatment of cisplatin-resistant cancer: A systematic review.

2012
Oxaliplatin is widely regarded as being active in cisplatin-resistant cancer. We undertook a systematic review of the literature to identify, describe and critique the clinical and pre-clinical evidence for the use of oxaliplatin in patients with ?cisplatinresistant? cancer.
openaire +1 more source

Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis

Journal of Cellular Physiology, 2018
Hsi-Hsien Hsu +2 more
exaly

Transport-Mediated Oxaliplatin Resistance Associated with Endogenous Overexpression of MRP2 in Caco-2 and PANC-1 Cells

Cancers, 2019
Riya Biswas, Ji He, Fabrice Merien
exaly

Oxaliplatin in resistant colorectal cancer: efficacy predictors

Inpharma Weekly, 2001
openaire +1 more source

Retention of activity by the new generation platinum agent AMD0473 in four human tumour cell lines possessing acquired resistance to oxaliplatin

European Journal of Cancer, 2002
S Y Sharp, C F O'Neill, Lloyd R Kelland
exaly

Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil

British Journal of Cancer, 2007
L-T Chen, Hsing-Pang Hsieh
exaly

Cetuximab plus capecitabine and oxaliplatin is an active salvage therapy for oxaliplatin-resistant or refractory colorectal cancer

Inpharma Weekly, 2007
openaire +1 more source